Inqtmol-CP Oral Suspension
By Inqtmol-CP
Rx
60ml Oral Suspension in a Bottle

Composition
Chlorpheniramine Maleate(1mg) + Paracetamol(250mg) + Phenylephrine(5mg)

Manufacturer - Incuity Pharma Pvt. Ltd.
Khasra No-581, Ground Floor, VPO- Naya Gaon Palio, Dehradun, 248007, Uttarakhand, India

Expires on or after
October, 2025

liver
When using Inqtmol-CP Oral Suspension, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Inqtmol-CP Oral Suspension. To ensure safe use, it is recommended to consult your doctor regarding the appropriate dosage if you have any liver-related concerns.

kidney
Inqtmol-CP Oral Suspension is likely safe for kidney disease patients. Limited data shows no need for dose adjustment, but those with end-stage kidney disease may experience increased drowsiness. Consult a doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Inqtmol-CP Oral Suspension.

driving
Inqtmol-CP Oral Suspension may reduce alertness, impact vision, and cause drowsiness and dizziness. It is not safe to drive if experiencing these symptoms.

pregnancy
Inqtmol-CP Oral Suspension is not recommended for use during pregnancy as it may pose risks to the developing baby based on animal studies. It is advisable to consult with your doctor for a thorough evaluation of the benefits and potential risks before using this medication.

breastfeeding
Inqtmol-CP Oral Suspension is considered safe during breastfeeding based on limited human data indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹66
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025